Editorial
Predicting the future of anti-tumor necrosis factor therapy
-
Correspondence: Cornelis L Verweij c.verweij@vumc.nl
Arthritis Research & Therapy 2009, 11:115 doi:10.1186/ar2724
No comments have yet been made on this article.